Table 3.
Comparison of the VAS score and the ODI of the two groups (x ± s).
| n | Indicator | Before treatment | 4 weeks after treatment | 8 weeks after treatment | P1 | P2 | P3 | |
|---|---|---|---|---|---|---|---|---|
| The control group | 62 | The VAS score | 6.56 ± 1.32 | 5.96 ± 1.62 | 5.24 ± 1.05 | 0.046∗ | 0.034∗ | 0.352 |
| The observation group | 64 | 6.83 ± 1.43 | 5.43 ± 0.67 | 3. 31 ± 1.76 | 0.043∗ | 0.023∗ | 0.035∗ | |
| P4 | 0.832 | 0.214 | 0.042∗ | |||||
| The control group | 62 | The ODI (%) | 38.42 ± 5.87 | 33.78 ± 4.82 | 31. 87 ± 4.73 | 0.045∗ | 0.041∗ | 0.276 |
| The observation group | 64 | 38.84 ± 6.03 | 27.65 ± 8.37 | 18. 43 ± 4.72 | 0.039∗ | 0.021∗ | 0.024∗ | |
| P4 | 0.965 | 0.167 | 0.032∗ |
Note.P1 indicates the P value of the VAS score or ODI at 4 weeks after treatment compared with the VAS score or ODI before treatment; P2 indicates the P value of the VAS score or ODI at 8 weeks after treatment compared with the VAS score or ODI before treatment; P3 indicates the P value of the VAS score or ODI at 8 weeks after treatment compared with the VAS score or ODI before treatment; P4 indicates the P value of VAS score or ODI comparison between two groups at different time points. ∗indicates a significant difference (P < 0.05).